X-38352256-A-G

Variant summary

Our verdict is Likely benign. The variant received -6 ACMG points: 0P and 6B. BP4_StrongBP6_Moderate

The ENST00000465127.1(ENSG00000250349):​c.172-313865A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.70 ( 19599 hom., 22417 hem., cov: 22)
Failed GnomAD Quality Control

Consequence

ENSG00000250349
ENST00000465127.1 intron

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:2

Conservation

PhyloP100: 0.985

Publications

2 publications found
Variant links:
Genes affected
OTC (HGNC:8512): (ornithine transcarbamylase) This nuclear gene encodes a mitochondrial matrix enzyme. The encoded protein is involved in the urea cycle which functions to detoxify ammonia into urea for excretion. Mutations in this enzyme lead to ornithine transcarbamylase deficiency, which causes hyperammonemia. [provided by RefSeq, May 2022]
OTC Gene-Disease associations (from GenCC):
  • ornithine carbamoyltransferase deficiency
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, G2P, Laboratory for Molecular Medicine, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -6 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BP6
Variant X-38352256-A-G is Benign according to our data. Variant chrX-38352256-A-G is described in ClinVar as [Benign]. Clinvar id is 516560.Status of the report is criteria_provided_single_submitter, 1 stars.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
OTCNM_001407092.1 linkc.-79-362A>G intron_variant Intron 2 of 11 NP_001394021.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ENSG00000250349ENST00000465127.1 linkc.172-313865A>G intron_variant Intron 3 of 8 5 ENSP00000417050.1 B4E171
OTCENST00000713758.1 linkc.-79-362A>G intron_variant Intron 2 of 11 ENSP00000519059.1
OTCENST00000713759.1 linkc.-88-15035A>G intron_variant Intron 1 of 9 ENSP00000519060.1
OTCENST00000713760.1 linkn.-79-362A>G intron_variant Intron 2 of 12 ENSP00000519061.1

Frequencies

GnomAD3 genomes
AF:
0.705
AC:
77430
AN:
109897
Hom.:
19605
Cov.:
22
show subpopulations
Gnomad AFR
AF:
0.685
Gnomad AMI
AF:
0.790
Gnomad AMR
AF:
0.692
Gnomad ASJ
AF:
0.781
Gnomad EAS
AF:
0.722
Gnomad SAS
AF:
0.760
Gnomad FIN
AF:
0.627
Gnomad MID
AF:
0.813
Gnomad NFE
AF:
0.718
Gnomad OTH
AF:
0.682
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
Data not reliable, filtered out with message: InbreedingCoeff
AF:
0.705
AC:
77464
AN:
109948
Hom.:
19599
Cov.:
22
AF XY:
0.695
AC XY:
22417
AN XY:
32234
show subpopulations
African (AFR)
AF:
0.685
AC:
20676
AN:
30166
American (AMR)
AF:
0.692
AC:
7163
AN:
10346
Ashkenazi Jewish (ASJ)
AF:
0.781
AC:
2056
AN:
2631
East Asian (EAS)
AF:
0.722
AC:
2520
AN:
3491
South Asian (SAS)
AF:
0.758
AC:
1976
AN:
2606
European-Finnish (FIN)
AF:
0.627
AC:
3525
AN:
5626
Middle Eastern (MID)
AF:
0.804
AC:
172
AN:
214
European-Non Finnish (NFE)
AF:
0.718
AC:
37832
AN:
52713
Other (OTH)
AF:
0.683
AC:
1010
AN:
1479
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
826
1652
2479
3305
4131
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
672
1344
2016
2688
3360
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.695
Hom.:
5956
Bravo
AF:
0.705

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Benign:1
Feb 12, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

OTC-related disorder Benign:1
Dec 01, 2023
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.92
CADD
Benign
6.1
DANN
Benign
0.74
PhyloP100
0.98
PromoterAI
0.0048
Neutral

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs5917572; hg19: chrX-38211509; API